Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report

Jorge H. Villafañe, Cesar Fernandez-de-las-Peñas, Paolo Pillastrini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The purpose of this case study is to present the findings of combining botulinum toxin type A (BoNT-A) and cervical spine manual therapy to address masseter muscle spasticity in a patient with Alzheimer-type dementia. Case Report: A 78-year-old woman with bilateral spasticity of the masseteric regions for 2 years was referred for physiotherapy. She had trismus and bruxism, and could neither close nor open her mouth normally; thus, she was unable to be fed orally in a normal manner. Intervention and Outcome: The patient underwent combined treatment with BoNT-A and cervical spine manual therapy. A medical physician (neurologist) performed the BoNT-A injections into 2 points at the center of the lower third of the masseter muscle. A physical therapist performed manual therapy interventions targeted at the cervical spine. Manual therapy started the day after the BoNT-A injection and continued for 5 sessions per week for a total period of 2 weeks. Clinical outcomes were measured including spasticity (Modified Ashworth Scale), functionality (Barthel Index), and jaw opening. Outcomes were conducted at baseline, 2 weeks after treatment, and at 2-month follow-up session after finishing the treatment. The patient improved in all of the outcomes at the end of treatment, and these results were maintained during the follow-up. After treatment, the patient was able to feed with minimal caregiver dependency because oral feeding was possible. Conclusion: The patient in this study responded positively to a combination of BoNT-A and manual therapy, resulting in decreased masseter muscles spasticity and improved trismus and bruxism.

Original languageEnglish
Pages (from-to)280-285
Number of pages6
JournalJournal of Chiropractic Medicine
Volume11
Issue number4
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Musculoskeletal Manipulations
Type A Botulinum Toxins
Hypertrophy
Alzheimer Disease
Spine
Masseter Muscle
Bruxism
Trismus
Muscle Spasticity
Therapeutics
Injections
Physical Therapists
Jaw
Caregivers
Mouth
Physicians

Keywords

  • Alzheimer disease
  • Botulinum toxin type A
  • Masseter muscle, cervical spine
  • Muscle spasticity
  • Physiotherapy
  • Stroke

ASJC Scopus subject areas

  • Chiropractics

Cite this

Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia : a case report. / Villafañe, Jorge H.; Fernandez-de-las-Peñas, Cesar; Pillastrini, Paolo.

In: Journal of Chiropractic Medicine, Vol. 11, No. 4, 12.2012, p. 280-285.

Research output: Contribution to journalArticle

@article{ab7b50a4b57a44c0b2cb8e2cfe3a9c42,
title = "Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report",
abstract = "Objective: The purpose of this case study is to present the findings of combining botulinum toxin type A (BoNT-A) and cervical spine manual therapy to address masseter muscle spasticity in a patient with Alzheimer-type dementia. Case Report: A 78-year-old woman with bilateral spasticity of the masseteric regions for 2 years was referred for physiotherapy. She had trismus and bruxism, and could neither close nor open her mouth normally; thus, she was unable to be fed orally in a normal manner. Intervention and Outcome: The patient underwent combined treatment with BoNT-A and cervical spine manual therapy. A medical physician (neurologist) performed the BoNT-A injections into 2 points at the center of the lower third of the masseter muscle. A physical therapist performed manual therapy interventions targeted at the cervical spine. Manual therapy started the day after the BoNT-A injection and continued for 5 sessions per week for a total period of 2 weeks. Clinical outcomes were measured including spasticity (Modified Ashworth Scale), functionality (Barthel Index), and jaw opening. Outcomes were conducted at baseline, 2 weeks after treatment, and at 2-month follow-up session after finishing the treatment. The patient improved in all of the outcomes at the end of treatment, and these results were maintained during the follow-up. After treatment, the patient was able to feed with minimal caregiver dependency because oral feeding was possible. Conclusion: The patient in this study responded positively to a combination of BoNT-A and manual therapy, resulting in decreased masseter muscles spasticity and improved trismus and bruxism.",
keywords = "Alzheimer disease, Botulinum toxin type A, Masseter muscle, cervical spine, Muscle spasticity, Physiotherapy, Stroke",
author = "Villafa{\~n}e, {Jorge H.} and Cesar Fernandez-de-las-Pe{\~n}as and Paolo Pillastrini",
year = "2012",
month = "12",
doi = "10.1016/j.jcm.2012.10.004",
language = "English",
volume = "11",
pages = "280--285",
journal = "Journal of Chiropractic Medicine",
issn = "1556-3707",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia

T2 - a case report

AU - Villafañe, Jorge H.

AU - Fernandez-de-las-Peñas, Cesar

AU - Pillastrini, Paolo

PY - 2012/12

Y1 - 2012/12

N2 - Objective: The purpose of this case study is to present the findings of combining botulinum toxin type A (BoNT-A) and cervical spine manual therapy to address masseter muscle spasticity in a patient with Alzheimer-type dementia. Case Report: A 78-year-old woman with bilateral spasticity of the masseteric regions for 2 years was referred for physiotherapy. She had trismus and bruxism, and could neither close nor open her mouth normally; thus, she was unable to be fed orally in a normal manner. Intervention and Outcome: The patient underwent combined treatment with BoNT-A and cervical spine manual therapy. A medical physician (neurologist) performed the BoNT-A injections into 2 points at the center of the lower third of the masseter muscle. A physical therapist performed manual therapy interventions targeted at the cervical spine. Manual therapy started the day after the BoNT-A injection and continued for 5 sessions per week for a total period of 2 weeks. Clinical outcomes were measured including spasticity (Modified Ashworth Scale), functionality (Barthel Index), and jaw opening. Outcomes were conducted at baseline, 2 weeks after treatment, and at 2-month follow-up session after finishing the treatment. The patient improved in all of the outcomes at the end of treatment, and these results were maintained during the follow-up. After treatment, the patient was able to feed with minimal caregiver dependency because oral feeding was possible. Conclusion: The patient in this study responded positively to a combination of BoNT-A and manual therapy, resulting in decreased masseter muscles spasticity and improved trismus and bruxism.

AB - Objective: The purpose of this case study is to present the findings of combining botulinum toxin type A (BoNT-A) and cervical spine manual therapy to address masseter muscle spasticity in a patient with Alzheimer-type dementia. Case Report: A 78-year-old woman with bilateral spasticity of the masseteric regions for 2 years was referred for physiotherapy. She had trismus and bruxism, and could neither close nor open her mouth normally; thus, she was unable to be fed orally in a normal manner. Intervention and Outcome: The patient underwent combined treatment with BoNT-A and cervical spine manual therapy. A medical physician (neurologist) performed the BoNT-A injections into 2 points at the center of the lower third of the masseter muscle. A physical therapist performed manual therapy interventions targeted at the cervical spine. Manual therapy started the day after the BoNT-A injection and continued for 5 sessions per week for a total period of 2 weeks. Clinical outcomes were measured including spasticity (Modified Ashworth Scale), functionality (Barthel Index), and jaw opening. Outcomes were conducted at baseline, 2 weeks after treatment, and at 2-month follow-up session after finishing the treatment. The patient improved in all of the outcomes at the end of treatment, and these results were maintained during the follow-up. After treatment, the patient was able to feed with minimal caregiver dependency because oral feeding was possible. Conclusion: The patient in this study responded positively to a combination of BoNT-A and manual therapy, resulting in decreased masseter muscles spasticity and improved trismus and bruxism.

KW - Alzheimer disease

KW - Botulinum toxin type A

KW - Masseter muscle, cervical spine

KW - Muscle spasticity

KW - Physiotherapy

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84870018888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870018888&partnerID=8YFLogxK

U2 - 10.1016/j.jcm.2012.10.004

DO - 10.1016/j.jcm.2012.10.004

M3 - Article

C2 - 23843761

AN - SCOPUS:84870018888

VL - 11

SP - 280

EP - 285

JO - Journal of Chiropractic Medicine

JF - Journal of Chiropractic Medicine

SN - 1556-3707

IS - 4

ER -